DE69606024D1 - Feststellung von antikörperproduktion - Google Patents

Feststellung von antikörperproduktion

Info

Publication number
DE69606024D1
DE69606024D1 DE69606024T DE69606024T DE69606024D1 DE 69606024 D1 DE69606024 D1 DE 69606024D1 DE 69606024 T DE69606024 T DE 69606024T DE 69606024 T DE69606024 T DE 69606024T DE 69606024 D1 DE69606024 D1 DE 69606024D1
Authority
DE
Germany
Prior art keywords
pct
antibody production
antibody
date aug
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69606024T
Other languages
English (en)
Other versions
DE69606024T2 (de
Inventor
Lars Reinhardt Haaheim
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PLASMACUTE AS, BERGEN, NO
Original Assignee
Lars Reinhardt Haaheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lars Reinhardt Haaheim filed Critical Lars Reinhardt Haaheim
Publication of DE69606024D1 publication Critical patent/DE69606024D1/de
Application granted granted Critical
Publication of DE69606024T2 publication Critical patent/DE69606024T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56994—Herpetoviridae, e.g. cytomegalovirus, Epstein-Barr virus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE69606024T 1995-02-21 1996-02-21 Feststellung von antikörperproduktion Expired - Lifetime DE69606024T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9503406.2A GB9503406D0 (en) 1995-02-21 1995-02-21 Detection of antibody production
PCT/GB1996/000392 WO1996026443A1 (en) 1995-02-21 1996-02-21 Detection of antibody production

Publications (2)

Publication Number Publication Date
DE69606024D1 true DE69606024D1 (de) 2000-02-10
DE69606024T2 DE69606024T2 (de) 2000-09-14

Family

ID=10769981

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69606024T Expired - Lifetime DE69606024T2 (de) 1995-02-21 1996-02-21 Feststellung von antikörperproduktion

Country Status (21)

Country Link
US (1) US6080552A (de)
EP (1) EP0811165B1 (de)
JP (1) JP3472929B2 (de)
CN (1) CN1098460C (de)
AT (1) ATE188551T1 (de)
AU (1) AU709591B2 (de)
CA (1) CA2213083C (de)
CZ (1) CZ289582B6 (de)
DE (1) DE69606024T2 (de)
DK (1) DK0811165T3 (de)
ES (1) ES2140821T3 (de)
FI (1) FI117911B (de)
GB (1) GB9503406D0 (de)
GR (1) GR3032740T3 (de)
HU (1) HU225687B1 (de)
NO (1) NO317151B1 (de)
NZ (1) NZ301770A (de)
PL (1) PL182061B1 (de)
PT (1) PT811165E (de)
RU (1) RU2197733C2 (de)
WO (1) WO1996026443A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0955544A1 (de) * 1998-05-06 1999-11-10 Hölzel Diagnostika Handels GmbH Verfahren zum Erfassen von Primärsignalen bei der Zellkommunikation von Zellen des Immunsystems
GB9913819D0 (en) 1999-06-14 1999-08-11 Plasmacute As Assay
GB0325483D0 (en) * 2003-10-31 2003-12-03 Plasmacute As Assay
US20050240353A1 (en) * 2004-04-21 2005-10-27 Hoffmann Technologies Corporation Reagents, devices and methods for proteomic analysis with applications including diagnostics, vaccines, quality control and research
JP4412732B2 (ja) * 2005-04-19 2010-02-10 独立行政法人国立高等専門学校機構 リンパ球を利用した抗体検査方法および病原体特定方法
DE102007052518A1 (de) * 2007-10-29 2009-04-30 Autoimmun Diagnostika Gmbh Verfahren zur in vitro-Diagnose und/oder in vitro- Therapieverfolgung von Infektionen
AU2015257417A1 (en) 2014-05-05 2016-11-03 Cembre S.P.A. Machine for the application and / or removal of connecting fasteners for rails
RU2756764C1 (ru) * 2021-06-09 2021-10-05 Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр терапии и профилактической медицины" Министерства здравоохранения Российской Федерации (ФГБУ "НМИЦ ТПМ" Минздрава России) Способ определения функциональной активности системы комплемента человека для прогноза тяжести течения системной воспалительной реакции

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5019497A (en) * 1984-11-09 1991-05-28 Lennart Olsson Human squamous lung carcinoma cell specific antigens and antibodies
US4707443A (en) * 1985-04-19 1987-11-17 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Soluble interleukin-2 receptor as a disease indicator and a method of assaying the same
CA2011099A1 (en) * 1989-04-19 1990-10-19 Stephen C. Wardlaw Determination of lymphocyte reactivity to specific antigens in blood
US5188942A (en) * 1990-10-09 1993-02-23 Consultants For Applied Biosciences, Inc. Method for determining bluetongue virus antibodies in serum

Also Published As

Publication number Publication date
DK0811165T3 (da) 2000-05-08
AU4726896A (en) 1996-09-11
PT811165E (pt) 2000-04-28
FI973418A0 (fi) 1997-08-20
HU225687B1 (en) 2007-06-28
DE69606024T2 (de) 2000-09-14
US6080552A (en) 2000-06-27
AU709591B2 (en) 1999-09-02
FI117911B (fi) 2007-04-13
EP0811165A1 (de) 1997-12-10
PL182061B1 (pl) 2001-10-31
ATE188551T1 (de) 2000-01-15
HUP9801448A2 (hu) 1998-10-28
NO973823D0 (no) 1997-08-20
HUP9801448A3 (en) 2000-09-28
CZ263497A3 (cs) 1998-02-18
JP3472929B2 (ja) 2003-12-02
PL322209A1 (en) 1998-01-19
JPH11500226A (ja) 1999-01-06
GR3032740T3 (en) 2000-06-30
CZ289582B6 (cs) 2002-02-13
EP0811165B1 (de) 2000-01-05
FI973418A (fi) 1997-08-20
CA2213083A1 (en) 1996-08-29
NO973823L (no) 1997-10-20
RU2197733C2 (ru) 2003-01-27
WO1996026443A1 (en) 1996-08-29
NZ301770A (en) 1999-04-29
ES2140821T3 (es) 2000-03-01
CN1176000A (zh) 1998-03-11
CA2213083C (en) 2007-12-04
CN1098460C (zh) 2003-01-08
GB9503406D0 (en) 1995-04-12
NO317151B1 (no) 2004-08-30

Similar Documents

Publication Publication Date Title
DK0805983T3 (da) Fremgangsmåe og forbindelser til magnetorelaksometrisk detection af analytter og anvendelse deraf
DK0557350T3 (da) Assay for glycerede blodproteiner
DK0483194T3 (da) IgG3-antistoffer med forkortet hængselsregion og en komplementaktiveringstest
CY1107621T1 (el) Μεθοδος ανιχνευσης αντισωματων σε ενα δειγμα
ATE120550T1 (de) Verfahren zum nachweis von malignen erkrankungen.
DE59107797D1 (de) Verfahren zum Nachweis von phosphoryliertes Tyrosin enthaltenden Proteinen
NO964015L (no) Fremgangsmåte for påvisning av kalpain-aktivering og identifisering av kalpain-inhibitorer
DE69606024T2 (de) Feststellung von antikörperproduktion
DE69214843T2 (de) Verfahren zum nachweis von beschädigungen des magenepithels
DE69521145D1 (de) Verfahren zur kompetitiven bestimmung eines haptens
DK1192469T3 (da) Assay
ATE209359T1 (de) Bestimmung von freiem und komplexiertem trypsinogen-2
ATE130099T1 (de) Verfahren zum nachweis von antikörpern gegen streptokinase.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: PLASMACUTE AS, BERGEN, NO

8381 Inventor (new situation)

Inventor name: HAAHEIM, LARS REINHARDT, BERGEN, NO